This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
NMDA receptor: Difference between revisions
Jump to navigation
Jump to search
>Kaylee No edit summary |
>Unity Added stub and references section |
||
| Line 1: | Line 1: | ||
{{headerpanel|{{stub}}}} | |||
==Structure== | ==Structure== | ||
==Function== | ==Function== | ||
== | ==Role of NMDA receptors in excitotoxicity== | ||
==Drugs which act on the NMDA receptor== | ==Drugs which act on the NMDA receptor== | ||
<div class="flex-panel"> | <div class="flex-panel"> | ||
| Line 55: | Line 56: | ||
</div> | </div> | ||
</div> | </div> | ||
==References== | |||
{{references}} | |||
Revision as of 17:02, 12 April 2018
 |
This article is a stub. As such, it may contain incomplete or wrong information. You can help by expanding it. |
Structure
Function
Role of NMDA receptors in excitotoxicity
Drugs which act on the NMDA receptor
Dissociatives
-
- 2-Fluorodeschloroketamine (2-FDCK)
- 3-MeO-PCMo
- 3-MeO-PCP
- 3-MeO-PCE
- 4-MeO-PCP
- DCK
- Ketamine
- Methoxetamine (MXE)
- Methoxyketamine
- O-PCE
- Phencyclidine (PCP)
- Dextromethorphan (DXM)
- Dextrorphan (DXO)
- Diphenidine
- Methoxphenidine (MXP)
- Ephenidine
- Myristicin
- Nitrous oxide
- Xenon
- Memantine
Partial Antagonists and Modulators
References
 |
This article does not cite enough references. You can help by adding some. |